Pancreatic Cancer
Multislice spiral CT can give diagnostic detail and determine resectability
Published in Cancer Weekly, April 8th, 2003
"The purpose of our study was to evaluate multislice computed tomography (MSCT) in the assessment of patients with clinical, laboratory, and US suspicion of pancreatic neoplasm, and to evaluate resectability status. Forty-six patients with a suspected pancreatic tumor underwent MSCT," researchers in Italy report.
"After a preliminary precontrast survey, a postcontrast scan was performed in the arterial and portal venous phase with the following protocol: 4x1-mm collimation; 1.25 mm and 5 mm slice thickness width, respectively; and 1 mm and 5 mm reconstruction interval. In...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-04-08)
More Articles from Cancer Weekly
- Cancer Therapy
Researchers discover new method to treat cancer - Liver Cancer
Metastasis gene may be useful for diagnosis and treatment - Biomarkers
Several genes may be reliable markers for primary liver cancer - Breast Cancer
The tumor suppressor maspin inhibits angiogenesis in breast malignancies - Cancer Screening
Hispanic women in border states less likely to receive screening for breast, cervical cancers - Lung Cancer
Treatment improves with better timing - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
